期刊文献+

耳穴压豆联合草酸艾司西酞普兰片治疗抑郁症临床研究 被引量:8

Clinical Study on Auricular Point Pressing with Beans Combined with Escitalopram Oxalate Tablets for Depression
下载PDF
导出
摘要 目的:观察耳穴压豆联合草酸艾司西酞普兰片治疗抑郁症的临床疗效及对患者神经递质的影响。方法:选取80例抑郁症患者,按随机数字表法分为对照组和观察组各40例。对照组给予草酸艾司西酞普兰片治疗,观察组在对照组基础上加用耳穴压豆治疗,2组均治疗1个月。比较2组临床疗效;比较2组治疗前后汉密尔顿抑郁量表(HAMD)评分、症状评分及神经递质水平。结果:观察组总有效率90.00%,高于对照组72.50%(P<0.05)。治疗后,2组HAMD评分均较治疗前降低(P<0.05),观察组HAMD评分低于对照组(P<0.05)。治疗后,2组情绪低落、睡眠障碍、思维迟缓评分均较治疗前降低(P<0.05),观察组情绪低落、睡眠障碍、思维迟缓评分均低于对照组(P<0.05)。治疗后,2组去甲肾上腺素(NE)、5-羟色胺(5-HT)、多巴胺(DA)、谷氨酸(Glu)、γ-氨基丁酸(GABA)水平均较治疗前升高(P<0.05),观察组NE、5-HT、DA、Glu、GABA水平均高于对照组(P<0.05)。结论:耳穴压豆联合草酸艾司西酞普兰片治疗抑郁症,可有效缓解患者的临床症状,调节神经递质表达水平,具有较好的抗抑郁效果。 Objective:To observe the clinical effect of the therapy of auricular point pressing with beans combined with escitalopram oxalate tablets on depression and its effect on neurotransmitter in patients. Methods:A total of 80 patients with depression were divided into the control group and the observation group according to the random number table method,with 40 cases in each group. The control group was treated with escitalopram oxalate tablets,and the observation group was additionally treated with auricular point pressing with beans based on the treatment of the control group. Both groups were treated for one month. The clinical effects in the two groups were compared. Before and after treatment, the scores of Hamilton Rating Scale for Depression(HAMD),syndrome scores and levels of neurotransmitter expression were compared between the two groups. Results:The total effective rate was 90.00% in the observation group,higher than that of 72.50%in the control group(P<0.05). After treatment,the scores of HAMD in the two groups were decreased when compared with those before treatment(P<0.05),and the score of HAMD in the observation group was lower than that in the control group(P<0.05). After treatment, the scores of depression, sleep disorder and retardation of thinking in the two groups were decreased when compared with those before treatment(P<0.05),and the above scores in the observation group were lower than those in the control group(P<0.05). After treatment,the levels of norepinephrine(NE),5-hydroxytryptamine(5-HT),dopamine(DA),glutamate(Glu) and γ-aminobutyric acid(GABA) in the two groups were increased when compared with those before treatment(P<0.05),and the above levels in the observation group were higher than those in the control group(P<0.05). Conclusion: The therapy of auricular point pressing with beans combined with escitalopram oxalate tablets for depression can effectively alleviate the clinical symptoms of patients and regulate the expression level of neurotransmitters,with great antidepressant effect.
作者 李旭红 陈丽艳 施旭爱 LI Xuhong;CHEN Liyan;SHI Xu'ai
出处 《新中医》 CAS 2022年第8期192-195,共4页 New Chinese Medicine
关键词 抑郁症 耳穴压豆 草酸艾司西酞普兰片 汉密尔顿抑郁量表 症状评分 神经递质 Depression Auricular point pressing with beans Escitalopram oxalate tablets Hamilton Rating Scale for Depression Syndrome scores Neurotransmitter
  • 相关文献

参考文献6

二级参考文献79

  • 1昂秋青.抑郁症与神经系统疾病[J].上海精神医学,2003,15(1):46-49. 被引量:2
  • 2张峰,曹仲伟,张学杰,李法曾.柴胡对大鼠慢性应激抑郁模型脑单胺类神经递质及其代谢物含量的影响[J].山东中医药大学学报,2005,29(3):224-226. 被引量:50
  • 3陈文垲,周玲,梅晓云,彭昌孝,李国春,黄云,陈文姬,彭计红.从临床流行病学调查探讨抑郁症中医病机规律[J].南京中医药大学学报,2005,21(5):273-276. 被引量:36
  • 4郭春荣,许维春,唐卫东,马德林,岳晓斌,谢东.抑郁症患者脑电超慢涨落检测分析[J].临床精神医学杂志,2006,16(4):226-227. 被引量:20
  • 5O'Leary OF, Dinah TG, Cryan JF. Faster, better, stronger : towards new antidepressant therapeutic strategies [ J ]. Eur J Pharmacol, 2015,753:32-50. DOI: 10. lO16/j.ejphar.2014.07.046.
  • 6Montgomery SA, Nielsen RZ, Poulsen LH, et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin re- uptake inhibitor or serotonin-noradrenaline reuptake inhibitor treat- ment switched to vortioxetine or agomelatine [ J ]. Hum Psychophar-maeo1,2014,29 ( 5 ) :470-482. DOI : 10.1002/hup.2424.
  • 7Blum SI, Tourkodimitris S, Ruth A. Evaluation of functional health and well-being in patients receiving levomilnacipran ER for the treatment of major depressive disorder [ J ]. J Affect Disord, 2015, 170:230-236. DOt : 10.1016/j.jad.2014.09.005.
  • 8Asnis GM, Henderson MA. Levomilnacipran for the treatment of major depressive disorder: a review [ J ]. Neuropsyehiatr Dis Treat, 2015,11 : 125-135. DOI : 10.2147/NDT.S54710.
  • 9Learned S, Craft O, Roychowdhury S, et al. Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treat- ment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials[J]. J Psychopharma- col, 2012,26 ( 5 ) : 653 -662. DOI : 10.1177/0269881111424931.
  • 10Wang Y, Chang T, Chen YC, et al. Quetiapine add-on therapy im- proves the depressive behaviors and hippocampal neurogenesis in fluoxetine treatment resistant depressive rats[ J]. Behav Brain Res, 2013,253:206-211. DOI : 10.1016/j.bbr.2013.07.021.

共引文献181

同被引文献151

引证文献8

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部